Ken Griffin Stryker Corp Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$315.94 - $371.96 $16.6 Million - $19.5 Million	52,500 Added 23.62%	274,800 $99.3 Million
Q2 2024 Aug 14, 2024	SELL	$324.3 - $354.67 $11.9 Million - $13.1 Million	-36,800 Reduced 14.2%	222,300 $75.6 Million
Q1 2024 May 15, 2024	BUY	$293.94 - $358.71 $3.38 Million - $4.13 Million	11,500 Added 4.64%	259,100 $92.7 Million
Q4 2023 Feb 14, 2024	BUY	$253.85 - $299.46 $22.7 Million - $26.8 Million	89,600 Added 56.71%	247,600 $74.1 Million
Q3 2023 Nov 14, 2023	SELL	$266.54 - $302.43 $10.8 Million - $12.3 Million	-40,700 Reduced 20.48%	158,000 $43.2 Million
Q2 2023 Aug 14, 2023	SELL	$271.49 - $305.09 $3.75 Million - $4.21 Million	-13,800 Reduced 6.49%	198,700 $60.6 Million
Q1 2023 May 15, 2023	SELL	$246.13 - $285.47 $22.8 Million - $26.4 Million	-92,500 Reduced 30.33%	212,500 $60.7 Million
Q4 2022 Feb 14, 2023	SELL	$205.51 - $253.93 $55.7 Million - $68.8 Million	-270,800 Reduced 47.03%	305,000 $74.6 Million
Q3 2022 Nov 14, 2022	BUY	$189.27 - $231.83 $36.3 Million - $44.4 Million	191,700 Added 49.91%	575,800 $117 Million

2,228

285M

1.35M

1.6M

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $146B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.